The Sporting News is tracking live scoring updates and highlights from Eagles vs. Rams on Sunday. Follow for complete results ...

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Republican Indiana House members this week filed a bill that threatens to strip hospitals of their nonprofit status if they overcharge for services. The bill is part of mounting scrutiny by ...

Eli, you don’t look that good in a hoodie. But you’re gonna look great in a gold jacket. I’m sure that’s gonna happen and you deserve it so much to join Peyton in a gold jacket.

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and endoscopic response rates in patients with Crohn disease. The FDA has ...

In the meantime, here are few other highlights from BioPharma Dive’s time covering the JPM meeting. Biotech’s winter could last well past the changing of the seasons this year, if you ask ...

Watch more top videos, highlights, and B/R original content Still, it makes sense that Lombardi would want to quell the noise, as Belichick's first attempt at coaching in college would take a ...

Yesterday we examined highlights 11-15 from the 2024 season; today we’ll take a look at 6-10. 10. Taking Ohio State to the Wire. Nebraska went into Columbus one week after a 56-7 loss to ...

Gabe Morin, Nick Strand, and Nehemiah Schwinghammer each won all five of their bouts to lead Bemidji boys wrestling’s 2-3 performance for a 4th place showing at the Rick Lee Invitational on Friday and ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain ...

Eli Lilly’s CEO Dave Ricks cited stocking levels and unexpected market dynamics in Q4 2024 in the GLP-1RA market.

(Photo source: Reuters) Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other ... CEO David Ricks said last quarter’s 45% growth ...